Literature DB >> 1600667

Bone mastocytosis. A report of nine cases with a bone histomorphometric study.

C de Gennes1, D Kuntz, M C de Vernejoul.   

Abstract

Bone mastocytosis is characterized radiographically in some patients by diffuse osteosclerosis and in others by demineralization. The reason for these apparently conflicting bone features is unknown. Bone remodeling and marrow mastocytosis infiltration were studied in nine cases of mastocytosis with bone marrow involvement. Six men, ranging from 42 to 78 years of age, and three women, 43, 55, and 73 years old, comprised the series. Two patients had severe and diffuse osteosclerosis. Seven had diffuse demineralization, with crushed vertebrae in four, suggesting common osteoporosis. In three of the seven, cutaneous mastocytosis was absent. Bone biopsies were undecalcified and stained with toluidine blue. In the seven patients with demineralization, the number of marrow mastocytes was increased (154 +/- 24 versus 2 +/- 0.5/mm2 in normal postmenopausal osteoporosis). Mastocyte nodules covering 1-9% of the marrow area were present in all seven patients. These patients showed a significant increase in remodeling; bone formation rate was increased, coupled with a decrease in mean wall thickness. Concomitantly, osteoclast surfaces were increased, with an increased amount of bone resorbed. The two patients with diffuse osteosclerosis had a markedly different histology; mast cell infiltration was dramatically increased (mastocyte count greater than 1000/mm2) with diffuse marrow fibrosis. Bone volume was increased as well, and most of the bone was woven with an intratrabecular mineralization defect. High bone remodeling and decreased osteoblast activity can explain bone loss in mastocytosis with demineralization. Mastocytosis with osteosclerosis is characterized by a more extensive marrow mast-cell infiltration and fibrosis.

Entities:  

Mesh:

Year:  1992        PMID: 1600667

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy.

Authors:  Viktoria Ferencz; Szilvia Meszaros; Emoke Csupor; Edit Toth; Katalin Bors; Andras Falus; Csaba Horvath
Journal:  Osteoporos Int       Date:  2006-01-24       Impact factor: 4.507

2.  Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

Authors:  A Orfao; L Escribano; J Villarrubia; J L Velasco; C Cerveró; J Ciudad; J L Navarro; J F San Miguel
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.

Authors:  S Seitz; F Barvencik; T Koehne; M Priemel; P Pogoda; J Semler; H Minne; M Pfeiffer; J Zustin; K Püschel; C Eulenburg; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2013-02-23       Impact factor: 4.507

Review 4.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

5.  Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.

Authors:  M Laroche; J Bret; A Brouchet; B Mazières
Journal:  Clin Rheumatol       Date:  2006-08-11       Impact factor: 2.980

6.  Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss.

Authors:  L A Fitzpatrick; E Buzas; T J Gagne; A Nagy; C Horvath; V Ferencz; A Mester; B Kari; M Ruan; A Falus; J Barsony
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

7.  Case report of bone mastocytosis: total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the knee.

Authors:  H Moret; E Plihal; Y Saudan
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

8.  Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts.

Authors:  Martin Biosse-Duplan; Brigitte Baroukh; Michel Dy; Marie-Christine de Vernejoul; Jean-Louis Saffar
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

9.  Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b.

Authors:  R Weide; K Ehlenz; W Lorenz; E Walthers; M Klausmann; K H Pflüger
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.